We help patients with cancer find the right treatment, therapy or clinical trial.

We offer a number of tests to help clinicians understand which approved anti-cancer treatments should be most effective for their patients.

Our tests can also direct patients to off-label treatments and clinical trials, thus providing additional options if standard therapies are not suitable.

By allowing clinicians to avoid treatments that won’t work, we help hospitals treat patients in the most efficient and effective ways.

Highlighted DNA

What tests do you offer?

Although we offer a range of services to best fit the varied needs of customers, our core tests utilise Next Generation Sequencing (NGS) technology.

NGS technology allows us to examine multiple genes simultaneously, and thus gain a better understand of what is driving a patient’s cancer – and how we might treat it.

We offer tests examining 22 genes and 50 genes, and will soon offer access to a test covering over 300 genes.

We also currently offer non-NGS based single gene tests for treatment stratification in time-critical solid tumour cases, as well as tests for the analysis of B & T-Cell clonal expansion in suspected lymphoproliferative diseases.

We are constantly developing and validating new tests to support and expand the existing repertoire. A number of these will be launching throughout 2017, so please watch this space.

Take a look at all of our tests. Read more about what they can tell you.

When might I refer a patient?

Our tests can help patients with solid tumours, in common cancers including lung, colorectal and breast cancers, and melanoma.

You can use our tests for patients who have just been diagnosed, to make sure they get the right treatment from the word go.

You can also order tests for patients with more advanced cancers, who have perhaps exhausted their standard care options.

Find out more about what our tests can tell you.

Tumor Cells

Why choose SCMD?

We have extraordinary expertise within our team.

Our laboratory is a partnership between:

Sarah Cannon

Sarah Cannon

HCA’s global Cancer Institute. Its research arm not only focuses on advancing therapies for patients, but is one of the world’s leading clinical research organisations conducting clinical trials. Sarah Cannon has been a clinical trial leader in the majority of cancer therapies over the last 10 years.

HCA People

HCA Healthcare

An international healthcare company with access to world-class resources and research power, supporting thousands of patients across the US and UK.

DNA

Genomics Review Board

We are also supported by a team of expert scientists and clinicians who help HCA clinicians interpret and act on our test results.

Find out more about our background and our team.

How do I order a test?

NGS Based multi-gene tests

How do I order?
Download our referral form, and send it to us with a sample.
Don’t forget to check our sample requirements first.

How long before I get the results?
*Typically 8-10 working days from the point we receive the sample.

What will the results look like?
You can download an example NGS Somatic Variant Analysis Report.

Rapid-turnaround single gene tests

How do I order?
Download our referral form, and send it to us with a sample.
Don’t forget to check our sample requirements first.

How long before I get the results?
*We will deliver results within 2 working days of receipt.

What will the results look like?
You can download an example Single Gene Analysis Report.

EGFR ctDNA (plasma based) analysis

How do I order?
Download our referral form, and send it to us with the sample. Critical sample processing information is included at the top of the referral form.

How long before I get the results?
*Typically 2-3 working days from the point we receive the sample.

What will the results look like?
You can download an example Single Gene Analysis Report.

B & T-Cell Clonality

How do I order?
Download our referral form, and send it to us with a sample.
Don’t forget to check our sample requirements first.

How long before I get the results?
*Typically 8-10 working days from the point we receive the sample.

What will the results look like?
You can download an example B & T-Cell Analysis Report.

*Greater than 90% of samples are consistently (click here to see live data) reported within target turn-around time (TAT), but sometimes factors beyond our control mean that tests need to be repeated or that additional information and/or material is required before the analysis can commence. Such samples will always be reported as quickly as possible but may exceed target turn-around. Additionally, some samples may not meet the minimum requirements to be eligible for analysis, meaning that unfortunately they will have to be returned untested. To minimise the risk of this, please take a look at our sample requirements.

What’s the science?

We focus on Next Generation Sequencing: a technology that allows us to examine several genes at once to understand more about a patient’s cancer. Over the last few years it has rapidly become one of the most important technologies in molecular pathology.

Using Next Generation Sequencing can be quicker and more cost effective than using multiple single gene tests. It can also give much more information, and therefore potentially more options for patients.